RecruitingNCT07740590

Visual Adaptation and Quality of Life After Different IOL Implantation Strategies

Evaluation of Visual Adaptation and Optical Performance in Patients With Bilateral Multifocal or Mix-and-Match Intraocular Lens Implantation: A Longitudinal Observational Study

Sponsor

Sichuan Academy of Medical Sciences

Enrollment

264 participants

Start Date

Mar 1, 2025

Study Type

OBSERVATIONAL

Conditions

Cataract Aphakia - Lens Capsule Present

Summary

This longitudinal observational study aims to evaluate long-term visual adaptation trajectories, optical quality, and patient-reported outcomes in age-related cataract patients following bilateral implantation of multifocal or mix-and-match intraocular lenses (IOLs). Patients will be followed up longitudinally after surgery to systematically assess visual performance and quality of life.

Eligibility

Min Age: 18 YearsMax Age: 100 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Bifocal and EDOF IOL Mix-and-Match Implantation, a medical device called Bifocal and Monofocal IOL Mix-and-Match Implantation, and others for people with aphakia - lens capsule present and cataract. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 100 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEBilateral Bifocal IOL Implantation

Bilateral phacoemulsification with bifocal intraocular lens implantation in both eyes.

DEVICEBifocal and EDOF IOL Mix-and-Match Implantation

Bilateral phacoemulsification with bifocal intraocular lens implantation in one eye and EDOF intraocular lens implantation in the contralateral eye.

DEVICEBifocal and Monofocal IOL Mix-and-Match Implantation

Bilateral phacoemulsification with bifocal intraocular lens implantation in one eye and monofocal intraocular lens implantation in the contralateral eye.